Sterile, fresh concentrates of human red blood cells suspended in a specially designed sterile preservation medium have a stability of all six red blood cell parameters of over four months as measured in the Coulter Model S-Plus II. Substitution under sterile conditions of the unstable white blood cells for (commercially available) fixed (human) red blood cells is a well-established method to obtain simulated white blood cell suspensions of long-term stability.
References
1.
CavillI, ed. Methods in hematology, Vol 4 Quality control. Edinburgh, London, Melbourne and New York: Churchill Livingstone, 1982.
2.
KoepkeJAProtextorTJ.Quality assurance for multi-channel hematology instruments. Four years' experience with patient mean erythrocyte indices. Am J Clin Pathol1981; 75: 28–33.
3.
LappinTRJFarringtonCLNelsonMGMerrettJD.Intralaboratory quality control of hematology. Comparison of two systems. Am J Clin Pathol1979; 72: 426–31.
4.
PrangnellDRJohnsonPH.A new method of quality control for the Coulter model S Counter. J Clin Pathol1911; 30: 487–91.
5.
CohleSDSaleemAMakkaouiDE.Effects of storage of blood on stability of hematologic parameters. Am J Clin Pathol1981; 76: 67–9.
6.
SpaetheRTengerFLampartA.Artificial control materials—Haematology. In: RosalkiSB, ed. New approaches to laboratory medicine. Transaction of the 2nd Merz+Dade Exploratory Seminar, Düdingen, 11–12 June, 1981. Darmstadt: G-I-T. Verlag Ernst Giebeler, 1981: 19–36.
7.
LewisSM.Standards and reference preparations. In: LewisSMCosterJF, eds. Quality control in hematology. Symposium of the ICSH. London: Academic Press, 1975: 79–101.
8.
AnidoG.Preparation of quality control materials in clinical chemistry and haematology. Proc roy Soc Med.1975; 68: 624–9.
9.
Index of patents. Official Gazette US Patent Office. Government Printing Office, Washington.
10.
International Patent Classification, World Intellectual Property Organization. Carl Heymans Verlag. Munich.
11.
RiceEW.Hemoglobin. In: FaulknerWRMeitesS, eds. Selected methods of clinical chemistryVol 9. Washington DC: American Association for Clinical Chemistry; 1982: 263–6.
12.
FairbanksVF.Hemoglobin, hemoglobin derivatives and myoglobin. In: TietzN, ed. Fundamentals of Clinical Chemistry.Philadelphia: WB. Saunders, 1976: 414–5.
13.
International Committee for Standardization in Haematology. Recommendations for reference method for haemoglobinometry in human blood (ICSH standard EP 6/2: 1977) and specifications for international haemiglobincyanide reference preparation (ICSH standard EP 6/3: 1977)J Clin Pathol1978; 31: 139–43.
14.
Fenwal products, systems and methods. Travenol Laboratories, Inc., Deerfield, Ill. 60015 USA/Locatellikade 1, 1076 AZ Amsterdam.
15.
ReesinkHWVeldmanHHenrichsHJPrinsHKLoosJA.Removal of leukocytes from blood by fibre filtration. A comparison study on the performance of two commercially available filters. Vox Sang1982; 42: 281–8.
16.
LombartsAJPFLeijnseB.A white blood cell control of long-term stability. Clin Chim Acta1983; 129: 79–83.
17.
GrimesA J.Human red cell metabolism.Oxford: Blackwell Scientific Publications, 1980.
18.
TruterEJRossouwJJBoehmL.Studies on the ultra-structure of blood cells and the microaggregate fraction in stored human blood. Intensive Care Med.1981; 7: 115–9.
19.
BeutlerEKuhlWWestC.The osmotic fragility of erythrocytes after prolonged liquid storage and after reinfusion. Blood1982; 59: 1141–7.
20.
MuellerHSchmidtULutzHU.On the mechanism of red blood cell shape change and release of spectrinfree vesicles. Acta biol med germ1981; 40: 413–7.
